AXDXAccelerate Diagnostics, Inc

Nasdaq acceleratediagnostics.com


$ 1.82 $ -0.17 (-9.14 %)    

Thursday, 05-Sep-2024 11:39:23 EDT
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 1.69
$ 1.83
$ 1.70 x 100
$ 1.74 x 100
$ 1.82 - $ 1.85
$ 0.73 - $ 7.06
89,094
na
40.02M
$ 1.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-14-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-02-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 02-26-2015 12-31-2014 10-K
40 11-04-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 accelerate-diagnostics-q2-eps-050-beats-055-estimate-sales-299m-miss-301m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate o...

 accelerate-diagnostics-announces-completion-of-its-wave-pre-clinical-trial-designed-to-deliver-rapid-antimicrobial-susceptibility-testing-directly-from-positive-blood-culture-bottles-and-bacterial-isolated-colonies-to-report-accurate-results-within-45-hours-on-average

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful...

 accelerate-diagnostics-q1-2024-gaap-eps-088-misses-072-estimate-sales-2921m-miss-3000m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate...

 craig-hallum-maintains-hold-on-accelerate-diagnostics-lowers-price-target-to-1

Craig-Hallum analyst Alexander Nowak maintains Accelerate Diagnostics (NASDAQ:AXDX) with a Hold and lowers the price target ...

 accelerate-diagnostics-q4-eps-089-misses-062-estimate-sales-303m-miss-345m-estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

 why-accelerate-diagnostics-axdx-stock-is-down-38

Accelerate Diagnostics shares are trading lower by 38% during Friday's session. The company priced an underwritten public o...

 us-stocks-higher-schlumberger-earnings-beat-estimates

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market o...

 accelerate-diagnostics-announces-pricing-of-15m-public-offering-and-private-placement-the-public-offering-price-for-each-unit-is-150-and-the-public-offering-price-for-each-pre-funded-unit-is-149

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) (the "Company") today announced the pricing of an underwritten public offeri...

 why-accelerate-diagnostics-axdx-stock-hit-a-new-52-week-low-today

Accelerate Diagnostics shares are trading lower by 23.2% Tuesday morning. The company announced the initiation of a proposed un...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION